The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings

Valentina Lorenzetti; Chandni Hindocha; Kat Petrilli; Paul Griffiths; Jamie Brown; Álvaro Castillo-Carniglia; Jonathan P. Caulkins; Amir Englund; Mahmoud A. ElSohly; Suzanne H. Gage; Teodora Groshkova; Antoni Gual; David Hammond; Will Lawn; Hugo López-Pelayo; Jakob Manthey; Claire Mokrysz; Rosalie Liccardo Pacula; Margriet van Laar; Ryan Vandrey; Elle Wadsworth; Adam Winstock; Wayne Hall; H. Valerie Curran; Tom P. Freeman

doi:10.1111/add.15855

The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings

Valentina Lorenzetti, Chandni Hindocha, Kat Petrilli, Paul Griffiths, Jamie Brown, Álvaro Castillo-Carniglia, Jonathan P. Caulkins, Amir Englund, Mahmoud A. ElSohly, Suzanne H. Gage, Teodora Groshkova, Antoni Gual, David Hammond, Will Lawn, Hugo López-Pelayo, Jakob Manthey, Claire Mokrysz, Rosalie Liccardo Pacula, Margriet van Laar, Ryan VandreyElle Wadsworth, Adam Winstock, Wayne Hall, H. Valerie Curran, Tom P. Freeman

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1523-1525
Number of pages	3
Journal	Addiction
Volume	117
Issue number	6
DOIs	https://doi.org/10.1111/add.15855
State	Published - Jun 2022

Keywords

Assessment
cannabis
dose
iCannToolkit
international cannabis toolkit
measurement
standardization

ASJC Scopus subject areas

Psychiatry and Mental health
Medicine (miscellaneous)

Access to Document

10.1111/add.15855

Cite this

Lorenzetti, V., Hindocha, C., Petrilli, K., Griffiths, P., Brown, J., Castillo-Carniglia, Á., Caulkins, J. P., Englund, A., ElSohly, M. A., Gage, S. H., Groshkova, T., Gual, A., Hammond, D., Lawn, W., López-Pelayo, H., Manthey, J., Mokrysz, C., Liccardo Pacula, R., van Laar, M., ... Freeman, T. P. (2022). The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings. Addiction, 117(6), 1523-1525. https://doi.org/10.1111/add.15855

Lorenzetti, V, Hindocha, C, Petrilli, K, Griffiths, P, Brown, J, Castillo-Carniglia, Á, Caulkins, JP, Englund, A, ElSohly, MA, Gage, SH, Groshkova, T, Gual, A, Hammond, D, Lawn, W, López-Pelayo, H, Manthey, J, Mokrysz, C, Liccardo Pacula, R, van Laar, M, Vandrey, R, Wadsworth, E, Winstock, A, Hall, W, Curran, HV & Freeman, TP 2022, 'The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings', Addiction, vol. 117, no. 6, pp. 1523-1525. https://doi.org/10.1111/add.15855

@article{4f5c9d07b4c24a4095c537e4cb3babd2,

title = "The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings",

keywords = "Assessment, cannabis, dose, iCannToolkit, international cannabis toolkit, measurement, standardization",

author = "Valentina Lorenzetti and Chandni Hindocha and Kat Petrilli and Paul Griffiths and Jamie Brown and {\'A}lvaro Castillo-Carniglia and Caulkins, {Jonathan P.} and Amir Englund and ElSohly, {Mahmoud A.} and Gage, {Suzanne H.} and Teodora Groshkova and Antoni Gual and David Hammond and Will Lawn and Hugo L{\'o}pez-Pelayo and Jakob Manthey and Claire Mokrysz and {Liccardo Pacula}, Rosalie and {van Laar}, Margriet and Ryan Vandrey and Elle Wadsworth and Adam Winstock and Wayne Hall and Curran, {H. Valerie} and Freeman, {Tom P.}",

note = "Funding Information: This study was supported by the Society for the Study of Addiction, European Monitoring Centre for Drugs and Drug Addiction. H.L.P. works under the CERCA Programme/Generalitat de Catalunya and receives funding from the Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III through a {\textquoteleft}Juan Rodes{\textquoteright} contract (JR19/00025). V.L. was supported by a Val & Al Rosenstrauss Senior Research Fellowship and by an Australian Catholic University competitive Scheme. A.C.C. received funding from ANID—Millennium Science Initiative Program, no. NCS2021_003 and no. NCS2021_013. Funding Information: A.G. received funding from Novartis for work outside this area (a phase III cocaine trial). A.E. has received speaker a honorarium from GW Pharmaceuticals. A.W. is the founder of the Global Drug Survey. C.H. became a full‐time employee of GW Pharmaceuticals after the consensus meeting. D.H. has served as a paid expert witness on behalf of public health authorities in Canada in response to legal challenges from the cannabis industry. H.L. has received honoraria and travel grants from Janssen and Lundbeck. J.B. has received unrestricted research funding to study smoking cessation from companies who manufacture smoking cessation medications (Pfizer and J&J). R.V. receives consulting fees for Canopy Health Innovations and Syqe Medical Ltd, and is on the Scientific Advisory Board for MyMD Pharmaceuticals and Artiam Bio Inc. V.C. has consulted for Janssen. V.L., W.H., T.P.F., E.W., T.G., W.L., A.C.C., J.P.C., R.L.P., M.v.L., K.P., P.G., M.A.E., S.H.G., J M. and C M. have no competing interests to declare. Funding Information: This study was supported by the Society for the Study of Addiction, European Monitoring Centre for Drugs and Drug Addiction. H.L.P. works under the CERCA Programme/Generalitat de Catalunya and receives funding from the Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III through a ?Juan Rodes? contract (JR19/00025). V.L. was supported by a Val & Al Rosenstrauss Senior Research Fellowship and by an Australian Catholic University competitive Scheme. A.C.C. received funding from ANID?Millennium Science Initiative Program, no. NCS2021_003 and no. NCS2021_013.",

year = "2022",

month = jun,

doi = "10.1111/add.15855",

language = "English (US)",

volume = "117",

pages = "1523--1525",

journal = "Addiction",

issn = "0965-2140",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - The iCannToolkit

T2 - a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings

AU - Lorenzetti, Valentina

AU - Hindocha, Chandni

AU - Petrilli, Kat

AU - Griffiths, Paul

AU - Brown, Jamie

AU - Castillo-Carniglia, Álvaro

AU - Caulkins, Jonathan P.

AU - Englund, Amir

AU - ElSohly, Mahmoud A.

AU - Gage, Suzanne H.

AU - Groshkova, Teodora

AU - Gual, Antoni

AU - Hammond, David

AU - Lawn, Will

AU - López-Pelayo, Hugo

AU - Manthey, Jakob

AU - Mokrysz, Claire

AU - Liccardo Pacula, Rosalie

AU - van Laar, Margriet

AU - Vandrey, Ryan

AU - Wadsworth, Elle

AU - Winstock, Adam

AU - Hall, Wayne

AU - Curran, H. Valerie

AU - Freeman, Tom P.

N1 - Funding Information: This study was supported by the Society for the Study of Addiction, European Monitoring Centre for Drugs and Drug Addiction. H.L.P. works under the CERCA Programme/Generalitat de Catalunya and receives funding from the Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III through a ‘Juan Rodes’ contract (JR19/00025). V.L. was supported by a Val & Al Rosenstrauss Senior Research Fellowship and by an Australian Catholic University competitive Scheme. A.C.C. received funding from ANID—Millennium Science Initiative Program, no. NCS2021_003 and no. NCS2021_013. Funding Information: A.G. received funding from Novartis for work outside this area (a phase III cocaine trial). A.E. has received speaker a honorarium from GW Pharmaceuticals. A.W. is the founder of the Global Drug Survey. C.H. became a full‐time employee of GW Pharmaceuticals after the consensus meeting. D.H. has served as a paid expert witness on behalf of public health authorities in Canada in response to legal challenges from the cannabis industry. H.L. has received honoraria and travel grants from Janssen and Lundbeck. J.B. has received unrestricted research funding to study smoking cessation from companies who manufacture smoking cessation medications (Pfizer and J&J). R.V. receives consulting fees for Canopy Health Innovations and Syqe Medical Ltd, and is on the Scientific Advisory Board for MyMD Pharmaceuticals and Artiam Bio Inc. V.C. has consulted for Janssen. V.L., W.H., T.P.F., E.W., T.G., W.L., A.C.C., J.P.C., R.L.P., M.v.L., K.P., P.G., M.A.E., S.H.G., J M. and C M. have no competing interests to declare. Funding Information: This study was supported by the Society for the Study of Addiction, European Monitoring Centre for Drugs and Drug Addiction. H.L.P. works under the CERCA Programme/Generalitat de Catalunya and receives funding from the Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III through a ?Juan Rodes? contract (JR19/00025). V.L. was supported by a Val & Al Rosenstrauss Senior Research Fellowship and by an Australian Catholic University competitive Scheme. A.C.C. received funding from ANID?Millennium Science Initiative Program, no. NCS2021_003 and no. NCS2021_013.

PY - 2022/6

Y1 - 2022/6

KW - Assessment

KW - cannabis

KW - dose

KW - iCannToolkit

KW - international cannabis toolkit

KW - measurement

KW - standardization

UR - http://www.scopus.com/inward/record.url?scp=85126198342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126198342&partnerID=8YFLogxK

U2 - 10.1111/add.15855

DO - 10.1111/add.15855

M3 - Comment/debate

C2 - 35289010

AN - SCOPUS:85126198342

SN - 0965-2140

VL - 117

SP - 1523

EP - 1525

JO - Addiction

JF - Addiction

IS - 6

ER -

The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this